China Shineway Pharmaceutical Group Limited (OTCMKTS:CSWYY) Short Interest Update

China Shineway Pharmaceutical Group Limited (OTCMKTS:CSWYY) was the target of a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 295 shares, a growth of 213.8% from the August 31st total of 94 shares. Based on an average trading volume of 49 shares, the days-to-cover ratio is presently 6.0 days.

China Shineway Pharmaceutical Group Price Performance

China Shineway Pharmaceutical Group stock remained flat at C$21.49 during mid-day trading on Friday. China Shineway Pharmaceutical Group has a fifty-two week low of C$18.16 and a fifty-two week high of C$22.23. The stock has a fifty day moving average of C$19.22 and a 200 day moving average of C$19.05.

China Shineway Pharmaceutical Group Company Profile

China Shineway Pharmaceutical Group Ltd. is a Chinese pharmaceutical company focused on the development, manufacture and sale of traditional Chinese medicines and related healthcare products. Its portfolio includes prescription and over-the-counter medicines in forms such as injections, capsules, tablets, oral liquids and granules.

The company’s products address a range of therapeutic areas, including respiratory, cardiovascular, digestive and gynecological conditions. Its better-known traditional Chinese medicine products include Qingkailing and Shuanghuanglian formulations, which are marketed in multiple dosage forms.

China Shineway is headquartered in Shijiazhuang, Hebei Province, China, and primarily serves the Chinese pharmaceutical market through hospitals, pharmacies and other healthcare distribution channels.